Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The venous endothelial cell lipid membrane is the semi-permeable phospholipid bilayer that forms the innermost lining of the venous system. It plays a critical role in maintaining vascular homeostasis, regulating leukocyte adhesion, and acting as a barrier to fluid and solute exchange (PubMed, 11566018). In clinical practice, this membrane is the primary therapeutic target for sclerosant medications used to treat varicose veins and vascular malformations. Sclerosants like polidocanol and sodium tetradecyl sulfate act as detergents that solubilize the lipids and proteins within the membrane, causing immediate cell lysis and denudation of the vessel wall (StatPearls, NBK534213). This targeted destruction initiates a localized thrombotic and fibrotic process that results in the permanent occlusion and eventual resorption of the diseased vein (PubMed, 22455564). The efficacy of these treatments depends on the concentration of the drug and the duration of contact with the endothelial surface. Damage to this membrane, whether intentional or pathological, triggers a cascade of inflammatory signaling and platelet activation.
Detergent-mediated solubilization of membrane lipids and proteins, osmotic dehydration of endothelial cells, and chemical irritation leading to endothelial destruction, localized thrombosis, and vessel fibrosis (StatPearls, NBK534213; PubMed, 22455564).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Venous endothelial cell lipid membrane.